Endo International | ENDP - Ebitda



Ebitda Cambio Fecha
AbbVie USD 3.52B 828M 2025-09
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Coherus Biosciences USD -44.34M 9.82M 2025-03
Eli Lilly USD 7.88B 378.1M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.88B 290M 2025-09
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 30.48M 1.1M 2024-09
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Takeda JPY 448.13B 173.98B 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Xeris Pharmaceuticals USD 17.42M 8.83M 2025-09
Zoetis USD 1.04B 87M 2025-09